CEC

The Clinical Trial Centre (CEC) performs clinical studies. CEC has dedicated facilities and updated ophthalmological equipment. Clinical patient-oriented research involves characterizing disease progression and testing new discoveries by carrying out carefully controlled research studies in patients, i. e., clinical trials. This includes testing not only new drugs, but also new methods, devices, imaging and surgical procedures as well as well-designed prospective, observational, longitudinal studies.

SERVICES
  • Randomized clinical trials
  • Clinical research studies
  • Testing new drugs, methods, devices, imaging and surgical procedures
  • Prospective, observational, longitudinal studies.

The Clinical Trial Centre (CEC) performs clinical trials and studies with special emphasis on
ophthalmology, focusing on patient’s wellbeing. Clinical patient-oriented research involves characterizing disease progression and testing new discoveries by carrying out controlled research studies in patients, i. e., clinical trials. This includes testing not only new drugs, but also new methods, devices, imaging and surgical procedures as well as well-designed prospective, non-interventional, longitudinal studies. Our research is focused on age-related eye diseases with special emphasis on diabetic retinopathy and age-related macular degeneration.

CEC has proven expertise with relevant scientific publications in these areas and is a certified Clinical Site of Excellence by the EVICR.net – European Vision Institute Clinical Research Network since 2006. CEC has experienced and qualified staff and dedicated facilities to perform clinical research according to ICH GCP Guidelines and Data Protection compliant. In its daily routine, CEC uses an Electronic Medical Record integrated with the equipment’s imaging allowing a quick and easy access to the patient’s data.

Research Focus

Biomarkers of progression of Diabetic Retinopathy Vision Threatening Complications in Diabetic Retinopathy Progression Epidemiological characterization of AMD. Characterization of progression of AMD from intermediate to late forms of AMD Evaluation of novel treatment options for complications of Diabetic Retinopathy Validation Outcomes and testing treatments for sight threatening Age-Related Macular Degeneration

Areas of expertise

Retina: Identification of phenotypes and biomarkers of retinal disease progression Testing new methods of early diagnosis of macular edema and retinal vascular disease Characterisation of responders and non-responders to new available therapies of retinal disease Characterization of phenotypes of diabetic retinopathy Neurovascular degeneration in age-related disease   Glaucoma: Evaluation of new drugs for glaucoma treatment   Other: Optical Coherence Tomography in the diagnosis of neurological diseases Diagnostic correlations in imaging between brain and retina Eye fundus imaging as a predictor of systemic vascular disease Neurovascular degeneration in age-related disease

  • Director

    Inês Marques

  • Sub-Director

    Patrícia Barreto

  • Investigator

    André Coutinho

    Cláudia Farinha

    Conceição Lobo

    Cristina Fonseca

    Cristina Januário

    Daniela Guelho

    Filipe Mira Ferreira

    Gina Maria Alves

    Guilherme Castela

    Inês Laíns

    Inês Pereira Marques

    Isabel Pires

    João Figueira

    João Gil

    João Pedro Marques

    Joana Providência Costa

    José Cunha-Vaz

    Luís Pires

    Margarida Gonçalo

    Maria Filipa Ponces

    Maria Luísa Ribeiro

    Maria Luz Cachulo

    Rufino Silva

  • Laboratory Technician

    Filipe Martins

  • Study Coordinator

    Catarina Eloy

    Filipe Martins

    Marcela Pascoal

    Sandra Cristina Pardal

  • Technician for Diagnostic Procedures

    Ana Catarina Almeida

    Ana Cláudia Rocha

    Inês Pinto

    Marta Lopes

  • Nurse

    Aida Cristina Vitorino

    Maria do Céu Simões

    Paulo Marques

    Tânia Mesquita

  • Pharmacist

    Patrícia Barreto

    Rita Ribeiro

  • Secretary

    Sandra Cristina Pardal

  • Clients

    ‣ Alcon

    ‣ Alimera

    ‣ Allergan

    ‣ Bausch & Lomb

    ‣ Bayer

    ‣ Chiltern

    ‣ Eurotrials

    ‣ EyeTech

    ‣ Farmalabor

    ‣ IRIS Pharma

    ‣ Lilly

    ‣ Merck Sharp & Dohme

    ‣ Novartis

    ‣ OM Pharma

    ‣ Pfizer

    ‣ Pharmaceutical Product Development

    ‣ Pharmacia Corporation

    ‣ Sanofi-Aventis

    ‣ Servier

    ‣ Théa